![](/img/cover-not-exists.png)
FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Beaver, J. A., Amiri-Kordestani, L., Charlab, R., Chen, W., Palmby, T., Tilley, A., Fourie Zirkelbach, J., Yu, J., Liu, Q., Zhao, L., Crich, J., Chen, X. H., Hughes, M., Bloomquist, E., Tang, S., SridLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-15-1185
Date:
August, 2015
File:
PDF, 427 KB
english, 2015